$5.240
-0.202 (-3.85%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
BMGL Prediction & Forecast by Similar Chart Analysis
Alphio's BMGL stock price prediction model matches the current Basel Medical Group Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.19 (-0.96%). The 1-week path is $5.21 (-0.51%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Basel Medical Group Ltd Stock?
Basel Medical Group Ltd (BMGL) is currently not a strong buy due to its recent performance and financial instability. The stock has seen a significant decline of 78.17% over the past year and has a current price of $5.24, which is below its 200-day simple moving average of $7.905. Although it regained Nasdaq compliance on July 10, 2026, this was after a reverse stock split, which often raises concerns among investors. The RSI is at 50.645, indicating a neutral momentum, and the forward P/E ratio is at 0, suggesting uncertainty about future earnings. The main risk is the high debt to equity ratio of 137.69%, which indicates potential financial distress.
BMGL stock price ended at $5.24 on Friday, after losing -3.85%
Basel Medical Group Ltd (BMGL) last closed at $5.24, losing -3.85%. These facts feed the 1-day and 1-week BMGL price prediction above.
Forecast Drivers
Basel Medical Group Ltd (BMGL) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches BMGL, ranked by similarity.
Seasonality analysis for BMGL
Historically the probability of a positive August return for BMGL is 0.00%. January offers the highest probability of a positive month at 95.00%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for BMGL
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $2.57 | $2.90 | $3.36 | -44.69% |
| Sep 2026 | $2.36 | $2.70 | $3.00 | -48.50% |
| Oct 2026 | $1.66 | $2.14 | $2.38 | -59.12% |
| Nov 2026 | $1.76 | $2.24 | $2.31 | -57.21% |
| Dec 2026 | $2.01 | $2.17 | $2.44 | -58.56% |
In 2026, Basel Medical Group Ltd (BMGL) is projected to range from $1.66 to $3.36.
Basel Medical Group Ltd 2026 monthly forecast
In Aug 2026, Basel Medical Group Ltd is projected to average $2.90, with a low of $2.57 and high of $3.36.
In Sep 2026, Basel Medical Group Ltd is projected to average $2.70, with a low of $2.36 and high of $3.00.
In Oct 2026, Basel Medical Group Ltd is projected to average $2.14, with a low of $1.66 and high of $2.38.
In Nov 2026, Basel Medical Group Ltd is projected to average $2.24, with a low of $1.76 and high of $2.31.
In Dec 2026, Basel Medical Group Ltd is projected to average $2.17, with a low of $2.01 and high of $2.44.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.